Cogent Biosciences CEO Andrew Robbins' 2023 pay jumps 80% to $7.9M
Cogent Biosciences reports 2023 executive compensation
By ExecPay News
Published: April 23, 2024
Cogent Biosciences reported fiscal year 2023 executive compensation information on April 23, 2024.
In 2023, three executives at Cogent Biosciences received on average a compensation package of $4.6M, a 70% increase compared to previous year.
Average pay of disclosed executives at Cogent Biosciences
Andrew Robbins, Chief Executive Officer, received $7.9M in total, which increased by 80% compared to 2022. 63% of Robbins' compensation, or $5M, was in option awards. Robbins also received $394K in bonus, $656K in salary, $1.9M in stock awards, as well as $13K in other compensation.
Jessica Sachs, Chief Medical Officer, received a compensation package of $3M, which increased by 57% compared to previous year. 50% of the compensation package, or $1.5M, was in option awards.
John Robinson, Chief Scientific Officer, earned $3M in 2023, a 59% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 23, 2024.